Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Ordinary shares
-
Shares outstanding
-
49,942,911
-
Total 13F shares
-
47,287,653
-
Share change
-
+2,029,800
-
Total reported value
-
$1,402,998,146
-
Put/Call ratio
-
55%
-
Price per share
-
$29.67
-
Number of holders
-
115
-
Value change
-
+$60,274,162
-
Number of buys
-
57
-
Number of sells
-
46
Institutional Holders of Immunocore Holdings plc - Ordinary shares (IMCR) as of Q1 2025
As of 31 Mar 2025,
Immunocore Holdings plc - Ordinary shares (IMCR) was held by
115 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,287,653 shares.
The largest 10 holders included
T. Rowe Price Investment Management, Inc., WELLINGTON MANAGEMENT GROUP LLP, RTW INVESTMENTS, LP, FMR LLC, PRIMECAP MANAGEMENT CO/CA/, BAKER BROS. ADVISORS LP, TANG CAPITAL MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, Kynam Capital Management, LP, and Deep Track Capital, LP.
This page lists
115
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.